Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti-pseudomonal β-lactam: Does "S" equal success in the presence of resistance to other anti-pseudomonal β-lactams?
Thomas P LodiseLaura A PuzniakLie H ChenYun TianRong WeiTheresa M ImSara Y TartofPublished in: Pharmacotherapy (2021)
Further study is needed, but this exploratory analysis suggests that the full APBL susceptibility profile should be considered when selecting therapy for patients with P. aeruginosa HABP/VABP.